Novo Nordisk’s EVOKE Alzheimer’s Trial: What the Latest Update Means for NVO Investors
at www.tipranks.com (Fri, 10-Apr 12:30 PM)
Inhaled drug developer Avalyn files for U.S. IPO
at seekingalpha.com (Fri, 10-Apr 12:23 PM)
Eli Lilly’s (LLY) Market Share in India Dips as Weight-Loss Drug War Heats Up
at www.tipranks.com (Fri, 10-Apr 11:31 AM)
Eli Lilly’s (LLY) Market Share Dips as Weight-Loss Drug War Heats Up
at www.tipranks.com (Fri, 10-Apr 11:31 AM)
Hims & Hers’ Shift to Branded Obesity Drugs Pressures Stock — Will the Bet Pay Off?
at www.tipranks.com (Fri, 10-Apr 7:00 AM)
UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)
at www.tipranks.com (Fri, 10-Apr 6:26 AM)
EU eases delivery requirement for Novo Nordisk’s Wegovy
at seekingalpha.com (Thu, 9-Apr 9:52 AM)
Eli Lilly launches new weight loss pill Foundayo in U.S.
at seekingalpha.com (Thu, 9-Apr 7:33 AM)
Cheap semaglutide copies in India challenge Novo Nordisk, cut Eli Lilly’s lead: report
at seekingalpha.com (Thu, 9-Apr 4:51 AM)
CEO of top pharma lobby PhRMA to resign: Endpoints News
at seekingalpha.com (Wed, 8-Apr 12:39 PM)
SA analyst upgrades/downgrades: TSLA, NVO, MSFT, AEO
at seekingalpha.com (Wed, 8-Apr 11:20 AM)
Market Chameleon (Fri, 20-Mar 11:00 AM)
Market Chameleon (Fri, 20-Mar 7:07 AM)
NVO Credit Call Spread is Overpriced at $1.13; Theoretical Value $1.03
Market Chameleon (Mon, 23-Feb 12:10 PM)
How This NVO Iron Condor Can Net 66% in 9 Days
Market Chameleon (Mon, 23-Feb 11:38 AM)
